Form D · Other Health Care
Provecta Diagnostics, LLC - Series 15
Austin, TX · CIK 0001730093
Offering snapshot reported Feb 9, 2018 · SEC filing
- Reported sold
- $15.5K Offering amount: $20K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Jan 31, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 9, 2018 | Initial | $15,500 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-305251
Source: Form D, filed Feb 9, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert D. Straface | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2802 Flintrock Trace Suite 216
Austin, TX, 78738
Austin, TX, 78738